The FDA insisted Hikma conduct a further clinical study evaluating its generic version of GlaxoSmithKline’d blockbuster lung drug.
AstraZeneca expects a key lung cancer study of two immunotherapy drugs to produce overall survival results in the second half of 2018, rather than the first half.
A potent, expensive cholesterol drug sold by Regeneron Pharmaceuticals and Sanofi significantly reduced major adverse heart events in a huge study.
Shares of MyoKardia climbed after the company revealed positive results from a mid-stage clinical trial for obstructive hypertrophic cardiomyopathy.
AcelRx Pharmaceuticals intends to resubmit a New Drug Application for Dsuvia (sufenetanil sublingual tablet) for pain in Q2 2018 after receiving a Complete Response Letter in October 2017.
The funds raised will be used to prepare a New Drug Application and funnel into commercial preparation for Xeris Pharmaceuticals Inc.’s lead product candidate, a ready-to-use glucagon rescue pen to treat severe low blood sugar in diabetes patients and individuals with related disorders.
A Rhode Island doctor is to be sentenced after admitting that he took kickbacks from Insys Therapeutics Inc. in exchange for prescribing a fentanyl-based cancer pain drug produced by the company.
A U.S. government agency said Idaho could not allow health insurers to sell plans that do not comply with Obamacare, a sign that the Trump administration will enforce the law even as it takes regulatory actions to weaken the ACA.
Pfizer Inc.’s Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel disease, a U.S. Food and Drug Administration advisory committee concluded.
NEW YORK (March 8, 2018) — McCann Health, winner of an unprecedented total of three Network of the Year titles from the industry’s top three creative award shows in 2017, today announced the promotion of Briana Ferrigno, to President, McCann Global Health. McCann Global Health (MGH) is a specialist agency of McCann Health dedicated to […]
Abiomed Inc. agreed to pay $3.1 million to resolve a U.S. probe into allegations that the company sought to get doctors to use a line of heart pumps it produced by buying them lavish meals.
BX: Brand Experience Design Group is a full-service branding agency dedicated to the development of verbal, visual and sensory brand identities across healthcare and wellness.
Pfizer Inc. notified CytomX Therapeutics Inc. of its intent to terminate a five-year-old oncology collaboration with the Bay Area-based company.
Seven months after Prevail Therapeutics launched, the New York-based company secured $75 million in Series A financing to support the development of gene therapies for Parkinson’s disease and other neurodegenerative diseases.
U.S. health insurer Cigna Corp. will buy pharmacy benefits manager Express Scripts Holding Co., a tie-up that reflects pressure on healthcare companies to grow bigger to cut costs.
DiD, an advertising agency specializing in healthcare marketing, announced national certification as a Women-Owned Business Enterprise by the Women’s Business Enterprise National Council.
Sanofi and Evotec started exclusive talks over accelerating research into the treatment of infectious diseases and will form a new open innovation platform in this area, led by Evotec.
Roche named U.S. cancer expert William Pao head of the Swiss drugmaker’s Pharma Research and Early Development business after John Reed decided to leave for what it called personal reasons.
Heavy drinkers may be more likely than other adults to develop dementia, especially in middle age, a French study suggests.
Eisai and Merck agreed upon a strategic collaboration for the worldwide co-development and co-commercialization of Lenvima (lenvatinib mesylate), an orally available tyrosine kinase inhibitor.